Southampton
| Research Theme | PhD Project Title | PhD Supervisor | Faculty/School | Cohort Start Date | Funding |
|---|---|---|---|---|---|
| Reproductive Cell Biology | Can endometrial gland structure and function help us understand why some women are more at risk of miscarriage than others? | Jane Cleal | Medicine/Human Development and Health | 2023 | WMR/Rosetrees |
| Stem Cell Biology | Uncovering the drivers of non-alcoholic fatty liver disease progression using patient derived organoids | Nicole Prior | Medicine/Human Development and Health | 2023 | BSR |
| Neurodegenerative Diseases | Investigating the function of SLC15A3: a promising gene linked to Alzheimer’s disease | Diego Gomez-Nicola | Medicine/Clinical and Experimental Sciences | 2023 | MRC-DTP |
| Neurological Diseases | New chemical approaches to improve A-to-I RNA editing with the aim of restoring sight loss associated with oculocutaneous albinism (OCA) | Ysobel Baker | Medicine/Clinical and Experimental Sciences | 2023 | MRC-DTP/IfLS |
| Neurodegenerative Diseases | Studying the role of environmental factors on microglia in Alzheimer’s Disease using human brain organoids. | Diego Gomez-Nicola | Medicine/Clinical and Experimental Sciences | 2023 | MRC-DTP |
| Cancer | Investigating the role of NK-innate immune cell interactions in oesophageal cancer. | Matthew Blunt | Medicine/Cancer Sciences | 2023 | MRC-DTP |
| Cancer | Investigating the genomic structure, regulation and function of the low affinity FCGR cluster to improve cancer immunotherapy. | Jane Gibson | Medicine/Cancer Sciences | 2023 | WMR/CITF |
| Cancer | Investigating the association between Crown Like Structures and body composition parameters on the tumour-immune microenvironment in high risk breast cancer. | Constantinos Savva | Medicine/Cancer Sciences | 2023 | CRUK/CITF |
| Cancer | Identification and validation of novel therapeutic targets for the treatment of esophageal adenocarcinoma | Dean Bryant | Medicine/Cancer Sciences | 2023 | University of Southampton |
| Cancer | Investigation into the role of NKG2A in CAR-T and CAR-NK cell activation against lymphoma | Matthew Blunt | Medicine/Cancer Sciences | 2023 | CRUK/CITF |
| Cancer Immunology | The effect of existing immune memory on CD8+ T cell responses to in situ cancer vaccines | Edd James | Medicine/Cancer Sciences | 2023 | CRUK/CITF |
| Cancer Immunology | Investigating the structure:function relationships of a novel human myeloid checkpoint receptor (LILRB3) and its specific immunomodulating monoclonal antibodies | Ali Roghanian | Medicine/Cancer Sciences | 2023 | MRC iCASE |
| Immunity & Infection | Determining the modes of action and application for antimicrobial mix metal complexes in the presence of biofilms. | Sandra Wilks | Environmental and Life Sciences/Biology | 2024 | MRC iCASE |
| Cancer | Therapeutic targeting of hypoxia inducible factors to augment anti-cancer antibody immunotherapy | Matthew Carter | Medicine/Cancer Sciences | 2024 | MRC iCASE |
| Immunity & Infection | Next generation light controlled antimicrobials with “on-off” activity for the treatment of wound infections | Matthias Baud | Engineering and Physical Sciences/Chemistry | 2024 | MRC iCASE |
| Immunity & Infection | A multi-disciplinary study into air pollution-associated transition metal homeostasis in the lungs | Matt Loxham | Medicine/Clinical and Experimental Sciences | 2022 | MRC-DTP |
| Cancer | Understanding the immune microenvironment in rhabdomyosarcoma using a fully non-animal 3D model to test novel alternative treatments. | Zoë Walters | Medicine/Cancer Sciences | 2026 | MRC iCASE |
| Immunity & Infection | Exploring the function of exosomes in Mycobacterium tuberculosis host-pathogen interaction, and their effect on infection outcome | Liku Tezera | Medicine/Clinical and Experimental Sciences | 2022 | MRC-DTP |
| Regenerative Medicine | Developing an antimicrobial release strategy using nanoclay gels to treat osteomyelitis | Jon Dawson | Medicine/Human Development and Health | 2022 | MRC iCASE |
| Immunity & Infection | Rapid Detection of Human Pathogens in Ocular Surface Infectious Disease | Parwez Hossain | Medicine/Clinical and Experimental Sciences | 2026 | MRC iCASE |
| Cancer | APOBEC3A-mediated RNA editing as a source of cancer antigens: A proof-of-concept study | Tim Fenton | Medicine/Cancer Sciences | 2022 | Oddfellows |
| Cancer | Deciphering the role of GABAergic signalling in tumour vascularization | Yury Bogdanov | Medicine/Cancer Sciences | 2022 | WMR/CITF |
| Cancer | Understanding and improving the mechanisms of action of antiGD2 chemo-immunotherapy in Neuroblastoma | Juliet Gray | Medicine/Cancer Sciences | 2022 | WMR/CITF |
| Neurological Diseases | Understanding the response of human microglia to disease-specific Tau conformers | Diego Gomez-Nicola | Medicine/Clinical and Experimental Sciences | 2025 | MRC-DTP |
| Cancer/Bioinformatics | Transforming Public Single-cell Omics Data into Accessible Models for Enhanced Prediction and Understanding of Gene Regulation and Underlying Networks Across Cell Types and Species. | Owen Rackham | Medicine/Cancer Sciences | 2025 | MRC-DTP/IfLS |
| Neurological Diseases | Linking micro-scale genome topology and macro-scale nuclear architecture during neurodevelopment and disease | Emily Brookes | Medicine/Clinical and Experimental Sciences | 2025 | MRC-DTP |
| Cancer | Investigating epithelial MHC-class II expression and anti-tumour immunity in lung cancer | Chris Hanley | Medicine/Cancer Sciences | 2025 | WMR/CITF |
| Cancer | Identification of cancer neoantigen T cell receptor reactivity in oesophageal adenocarcinoma. | Samuel Luke Hill | Medicine/Cancer Sciences | 2025 | MRC iCASE |
| Cancer Immunology | Optimising B7-H3 CAR-iNKT cell therapy for solid tumours | Salah Mansour | Medicine/Cancer Sciences | 2025 | CITF |
| Cancer Immunology | Engineering off-the-shelf CAR therapies for optimal targeting of AML cells | Ali Roghanian | Medicine/Cancer Sciences | 2025 | MRC iCASE |
| Neurological Diseases | Molecular mechanisms of epigenetic priming after early life adversity. | Emily Brookes | Medicine/Clinical and Experimental Sciences | 2024 | MRC-DTP |
| Cancer | Investigating Metastases and the Lymph Node Microenvironment in Oesophageal Adenocarcinoma. | Dean Bryant | Medicine/Cancer Sciences | 2024 | MRC-DTP |
| Cancer/Chemistry | Development of boronic acid prodrug-hydrogel conjugates to improve pancreatic cancer chemotherapy. | George Williams | Medicine/Cancer Sciences | 2024 | MRC-DTP/IfLS |
| Cancer | Molecular mechanisms of high-risk Splenic Marginal Zone lymphoma. | Jon Strefford | Medicine/Cancer Sciences | 2024 | CRUK |
| Cancer | Establishing 3D culture model systems to study how inflammation subverts control of cell fate during carcinogenesis. | Tim Fenton | Medicine/Cancer Sciences | 2024 | WMR/CITF |
| Cancer | Targeting myeloid cells for improved antibody immunotherapy | Mark Cragg | Medicine/Cancer Sciences | 2024 | CRUK |
| Cancer | Extending the chemical space of mAb based cancer treatment with DNA nanostructures. | Sean Lim | Medicine/Cancer Sciences | 2024 | MRC-DTP/IfLS |
| Bioinformatics | Multimodal foundation models for the functional interpretation of the molecular basis of diseases | Owen Rackham | Medicine/Cancer Sciences | 2024 | University of Southampton |
| Cancer | Analysing the impact of differential antibody-mediated clustering of members of the TNF receptor superfamily. | Matthew Carter | Medicine/Cancer Sciences | 2025 | CITF |
| Cancer | Investigating the regulation of APOBEC3A in human cancers | Tim Fenton | Medicine/Cancer Sciences | 2025 | CITF |
